Nicole Macagno

8PUBLICATIONS
14CO-AUTHORS
Medical infection agents (incl. prions)Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2025
Cutaneous and Lymphangitic Infection Caused by Purpureocillium lilacinum in Immunocompromised Patients: A Case Report with a Narrative Review of the Literature.

Tommaso Lupia, Cristina Sarda, Francesca Canta

|Nov 09, 2024
Drug Survival and Clinical Course of Patients with Cancer Treated with Biologic Therapy for Psoriasis.

Nicole Macagno, Luca Mastorino, Michela Ortoncelli

|Sep 14, 2024
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience.

Gabriele Roccuzzo, Nicole Macagno, Pietro Grignani

|Jul 22, 2024
Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis®: Clinical Effectiveness in Real Life.

Luca Mastorino, Richard Borrelli, Nicole Macagno

|Jul 26, 2022
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course.

N Macagno, L Mastorino, M Rubatto

Pageof 2

Frequent Collaborators

7 joint publications

Simone Ribero

5 joint publications

Luca Mastorino

4 joint publications

Pietro Quaglino

2 joint publications

Marco Rubatto